epitope corresponding to amino acids 430-729 mapping at the C-terminus of BAP1 of human origin
recommended for detection of BAP1 of mouse, rat and human origin by WB, IP, IF and ELISA; also reactive with additional species, including equine, canine, bovine and porcine
BAP1 Background Information Mutations within the BRCA1 gene, localized to chromosome 17q, are believed to account for approximately 45% of families with increased incidence of both early-onset breast cancer and ovarian cancer. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. This protein contains a RING domain near the N-terminus and appears to encode a tumor suppressor. BARD1 (BRCA1-associated RING domain protein 1) and BAP1 (BRCA1-associated protein 1) have both been shown to bind to the N-terminus of BRCA1 and are potential mediators of tumor suppression. BARD1 contains an N-terminal RING domain and three tandem ankyrin repeats. The C-terminus of BARD1 contains a region with sequence homology to BRCA1, termed the BRCT domain. BAP1 is a ubiquitin hydrolase and has been shown to enhance BRCA1-mediated cell growth suppression.
BAP1 (H-300)
Click on image to enlarge
BAP1 (H-300): sc-28236. Western blot analysis of BAP1 expression in A-431 (A), HeLa (B) and SW480 (C) whole cell lysates.
BAP1 (H-300): sc-28236. Immunofluorescence staining of methanol-fixed HeLa cells showing nuclear localization.
BAP1 (H-300): sc-28236. Western blot analysis of BAP1 expression in non-transfected: sc-117752 (A) and human BAP1 transfected: sc-171879 (B) 293T whole cell lysates.
